MARKET WIRE NEWS

Bio-Rad Laboratories, Inc. (BIO) Q1 2025 Earnings Call Transcript

Source: SeekingAlpha

2025-05-01 22:35:30 ET

Bio-Rad Laboratories, Inc. (BIO)

Q1 2025 Earnings Conference Call

May 1, 2025, 05:30 PM ET

Company Participants

Edward Chung - Head of Investor Relations

Jon DiVincenzo - President and Chief Operating Officer

Roop Lakkaraju - Executive Vice President and Chief Financial Officer

Norman Schwartz - Chief Executive Officer

Conference Call Participants

Patrick Donnelly - Citigroup

Dan Leonard - UBS

Brandon Couillard - Wells Fargo

Conor McNamara - RBC Capital Markets

Jack Meehan - Nephron Research

Presentation

Operator

Ladies and gentlemen, thank you for standing by. My name is Desyree, and I will be your conference operator today. At this time, I would like to welcome everyone to the Bio-Rad First Quarter 2025 Earnings Results Conference Call and Webcast. [Operator Instructions]

I would now like to turn the conference over to Edward Chung, Head of Investor Relations. You may begin.

Edward Chung

Thanks, Desyree. Good afternoon, everyone, and thank you for joining us. Today, we will review the first quarter 2025 financial results and provide an update on key business trends for Bio-Rad.

With me on the call today are Norman Schwartz, our Chief Executive Officer; Jon DiVincenzo, President and Chief Operating Officer; and Roop Lakkaraju, Executive Vice President and Chief Financial Officer.

Before we begin our review, I would like to remind everyone that we'll be making forward-looking statements about management's goals, plans, and expectations, our future financial performance, and other matters. These statements are based on assumptions and expectations of future events that are subject to risks and uncertainties. Our actual results may differ materially from these plans, goals, and expectations. You should not place undue reliance on these forward-looking statements, and I encourage you to review our filings with the SEC, where we discuss in detail the risk factors in our business. The company does not intend to update any forward-looking statements made during the call today....

Read the full article on Seeking Alpha

For further details see:

Bio-Rad Laboratories, Inc. (BIO) Q1 2025 Earnings Call Transcript
Bio-Rad Laboratories Inc. Class A

NASDAQ: BIO

BIO Trading

11.5% G/L:

$277.42 Last:

471,754 Volume:

$274.72 Open:

mwn-alerts Ad 300

BIO Latest News

BIO Stock Data

$8,088,674,023
21,121,296
0.01%
179
N/A
Biotechnology & Life Sciences
Healthcare
US
Hercules

Subscribe to Our Newsletter

Link Market Wire News to Your X Account

Download The Market Wire News App